Xtant Medical Inc. (XTNT)
| Bid | 0.47 |
| Market Cap | 70.88M |
| Revenue (ttm) | 122.01M |
| Net Income (ttm) | -17.11M |
| EPS (ttm) | -0.12 |
| PE Ratio (ttm) | -4.25 |
| Forward PE | -9.17 |
| Analyst | Strong Buy |
| Ask | 0.56 |
| Volume | 10,402 |
| Avg. Volume (20D) | 80,395 |
| Open | 0.50 |
| Previous Close | 0.50 |
| Day's Range | 0.47 - 0.51 |
| 52-Week Range | 0.33 - 1.18 |
| Beta | 0.41 |
About XTNT
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect ...
Analyst Forecast
According to 1 analyst ratings, the average rating for XTNT stock is "Strong Buy." The 12-month stock price forecast is $3, which is an increase of 488.58% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago · seekingalpha.com
Xtant Medical Holdings, Inc. (XTNT) Q4 2024 Earnings Call TranscriptXtant Medical Holdings, Inc. (NYSE:XTNT ) Q4 2024 Results Conference Call March 6, 2025 4:30 PM ET Company Participants Brett Maas - Hayden IR Sean Browne - President & Chief Executive Officer Scott N...
3 weeks ago · accessnewswire.com
Xtant Medical Reports Fourth Quarter and Full Year 2024 Financial ResultsFull Year 2024 Revenue Growth of 28% Expects 2025 Revenue of $126 Million to $130 Million Without Need for Additional Capital BELGRADE, MT / ACCESS Newswire / March 6, 2025 / Xtant Medical Holdings, I...
4 weeks ago · accessnewswire.com
Xtant Medical to Issue Fourth Quarter and Year End 2024 Financial Results on March 6, 2025BELGRADE, MT / ACCESS Newswire / February 28, 2025 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal di...